Mamluk R - Search Results

1

Neurovascular congruence results from a shared patterning mechanism that utilizes Semaphorin3A and Neuropilin-1.

Bates D, Taylor GI, Minichiello J, Farlie P, Cichowitz A, Watson N, Klagsbrun M, Mamluk R, Newgreen DF. Bates D, et al. Among authors: mamluk r. Dev Biol. 2003 Mar 1;255(1):77-98. doi: 10.1016/s0012-1606(02)00045-3. Dev Biol. 2003. PMID: 12618135 Free article.

2

The role of neuropilin in vascular and tumor biology.

Klagsbrun M, Takashima S, Mamluk R. Klagsbrun M, et al. Among authors: mamluk r. Adv Exp Med Biol. 2002;515:33-48. doi: 10.1007/978-1-4615-0119-0_3. Adv Exp Med Biol. 2002. PMID: 12613541 Review.

3

VEGF is required for the maintenance of dorsal root ganglia blood vessels but not neurons during development.

Kutcher ME, Klagsbrun M, Mamluk R. Kutcher ME, et al. Among authors: mamluk r. FASEB J. 2004 Dec;18(15):1952-4. doi: 10.1096/fj.04-2320fje. Epub 2004 Oct 12. FASEB J. 2004. PMID: 15479766

4

Soluble neuropilin targeted to the skin inhibits vascular permeability.

Mamluk R, Klagsbrun M, Detmar M, Bielenberg DR. Mamluk R, et al. Angiogenesis. 2005;8(3):217-27. doi: 10.1007/s10456-005-9009-6. Epub 2005 Nov 19. Angiogenesis. 2005. PMID: 16328161

5

Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.

Mamluk R, Gechtman Z, Kutcher ME, Gasiunas N, Gallagher J, Klagsbrun M. Mamluk R, et al. J Biol Chem. 2002 Jul 5;277(27):24818-25. doi: 10.1074/jbc.M200730200. Epub 2002 May 1. J Biol Chem. 2002. PMID: 11986311 Free article.

6

Regulation of soluble neuropilin 1, an endogenous angiogenesis inhibitor, in liver development and regeneration.

Panigrahy D, Adini I, Mamluk R, Levonyak N, Bruns CJ, D'Amore PA, Klagsbrun M, Bielenberg DR. Panigrahy D, et al. Among authors: mamluk r. Pathology. 2014 Aug;46(5):416-23. doi: 10.1097/PAT.0000000000000121. Pathology. 2014. PMID: 24977735 Free PMC article.

7

VEGFA is necessary for chondrocyte survival during bone development.

Zelzer E, Mamluk R, Ferrara N, Johnson RS, Schipani E, Olsen BR. Zelzer E, et al. Among authors: mamluk r. Development. 2004 May;131(9):2161-71. doi: 10.1242/dev.01053. Epub 2004 Apr 8. Development. 2004. PMID: 15073147

8

Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin.

Satchi-Fainaro R, Mamluk R, Wang L, Short SM, Nagy JA, Feng D, Dvorak AM, Dvorak HF, Puder M, Mukhopadhyay D, Folkman J. Satchi-Fainaro R, et al. Among authors: mamluk r. Cancer Cell. 2005 Mar;7(3):251-61. doi: 10.1016/j.ccr.2005.02.007. Cancer Cell. 2005. PMID: 15766663 Free article.

9

The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.

Dineen SP, Sullivan LA, Beck AW, Miller AF, Carbon JG, Mamluk R, Wong H, Brekken RA. Dineen SP, et al. Among authors: mamluk r. BMC Cancer. 2008 Nov 27;8:352. doi: 10.1186/1471-2407-8-352. BMC Cancer. 2008. PMID: 19038046 Free PMC article.

10

Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2.

Mamluk R, Carvajal IM, Morse BA, Wong H, Abramowitz J, Aslanian S, Lim AC, Gokemeijer J, Storek MJ, Lee J, Gosselin M, Wright MC, Camphausen RT, Wang J, Chen Y, Miller K, Sanders K, Short S, Sperinde J, Prasad G, Williams S, Kerbel R, Ebos J, Mutsaers A, Mendlein JD, Harris AS, Furfine ES. Mamluk R, et al. MAbs. 2010 Mar-Apr;2(2):199-208. doi: 10.4161/mabs.2.2.11304. MAbs. 2010. PMID: 20190562 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters